BNK Capital Group

IPO

IPO Snapshot

Chandra Bhagat Pharma Ltd.

Issue Open Date	31-Jan-20
Issue Closing Date	06-Feb-20
Application Money	100
Allotment Money

Price Band ()	51 -
Minimum Bid Quantity.	2000
Issue Size (Shares)	2000000
Market Lot	1

Objective

The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:1. To Meet Incremental Working Capital Requirements 2. Setting up Distribution and Warehousing Centre’s 3. General Corporate Purpose 4. To meet Public Issue Expenses

Business Description

No Description found

Promoter's Holding

Total Share Capital	5313056
Offered to Public	2000000
Promoter's Holding (Pre-Issue)	95.82
Promoter's Holding (Post-Issue)	70.42

Address

Address :Flat No. 1 & 2
Gr. Floor
323
F
Bhagat Bhuvan Dr. Ambedkar Road
Matunga (East) City :Mumbai, State :Maharashtra Pincode :400019 Phone :022-24146154 / 24157205 / 24129162 Email : info@cbcpharma.net, export@cbcpharma.net Website : www.cbcpharma.com

Registrar

Link Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai

Listed at

BSE

Lead Manager

Beeline Broking Ltd.

Promoters

Hemant Chandravadan Bhagat
Pranav Hemant Bhagat

BNK Securities Pvt. Ltd

CIN No.:U67120WB1995PTC071182 (ISO 90001:2015 & ISO 27001:2013 Certified Company)

Registered Office: Mayfair Tower, 2,Palm Avenue,Kolkata-700 019

Tel:+91-33-4602-2160/61/62/63 Email:contact@bnkcapital.com

BNK Securities Pvt Ltd. MEMBERS OF NSE, BSE AND MSEI SEBI Registration no: INZ000220037

SEBI Registration No: MB / INM000011641 (Category I Merchant Banker), Research Analyst. Reg no INH300003520

DEPOSITORY PARTICIPANT SEBI Registration No-In-DP-673-2022, CDSL DP ID - 12060500.

AMFI certified Mutual Fund Distributor Registration No: ARN–86507

For any grievances, investors can contact at: grievance@bnkstockline.com, Tel:+91-33-4602-2160/61/62/63

BNK Capital

Open an Account

Open an Account

Registration Form

Login Form

IPO Snapshot